Study your flashcards anywhere!

Download the official Cram app for free >

  • Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

A key: Read text to speech.a key

image

Play button

image

Play button

image

Progress

1/49

Click to flip

49 Cards in this Set

  • Front
  • Back
Rate of fetal mortality in the US
6.60%
US Rank in the world in terms of fetal mortality
27th
Days after conception that human organogenesis occurs
17-56 days
Risk of congenital malformations in fetus of diabetic mother
3-4x increased
Dose of folic acid for neural tube defect prevention in general population
0.4mg
Percentage of pregnancies that are unintended
57%
Percentage of pregnancies that end in abortion
25%
Percentage of cardiac output going to placenta
50%
Risk of pregnancy per act of intercourse midcycle
17-30%
Failure rate of oral contraceptives with perfect to typical use
0.3-8%
Failure rate of Mirena IUD
0.10%
Typical number of days in the luteal phase
14
Mean number of days in human menstrual cycle
28
Average number of eggs a woman ovulates in a lifetimes
<500
Percentage of married couples who are satisfied with their sex lives
87%
Prevalence of erectile dysfunction in men ages 18-59
31%
Percentage of women in the community affected by urinary incontinence
30%
Percentage of urinary incontinence that can be significantly cured
80%
Mortality from necrotizing fasciitis
30-50%
High risk HPV (causes cervical cancer)
16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58
Low risk HPV types
6, 11, 42, 43, 44
Stage when most ovarian cancers (40%) are diagnosed
Stage III
Average age of menopause
51
Term pregnancy
37-40 weeks
Preterm pregnancy
20-36 weeks
Incidence of PCO in general population
3.5-7%
Increased breast cancer risk in patients with nonproliferative breast lesions and non-significant family history
none
Increased breast cancer risk in patients with proliferative lesions without atypia
1.5-2.0x’s
Increased breast cancer risk in patients with proliferative lesions with atypia
4-6x’s
Increased breast cancer risk in patients with carcinoma in situ
8-10x’s
General population risk of breast cancer by age 85
12.5% or 1 in 8
Breast cancer mortality in the US
27/100,000
Reduction in breast CA mortality in women ages 50-69 who are regularly screened
30%
Lifetime risk of breast cancer in patients with BRCA1 mutation
85%
Lifetime risk of breast cancer in patients with BRCA2 mutation
30-40%
Recall rate for further imaging after mammogram screening
9.40%
Sensitivity of general population screening mammogram in the US
65-75%
Specificity of general population screening mammogram in the US
90%
PPV for cancer of general population screening mammogram in the US (percentage of positive screening that have cancer diagnosed)
4.80%
Sensitivity of high risk population screening mammogram in the US
45%
Specificity of high risk population screening mammogram in the US
90%
Sensitivity of high risk population screening breast MRI in the US
71%
Specificity of high risk population screening breast MRI in the US
90%
Percentage of uterine cancer presenting in stage I
72%
Overall 5 year survival of endometrial cancer
73%
Ovarian cancer lifetime risk
1 in 60 to 1 in 70
Percentage of ovarian cancers occurring in women with genetic predisposition
5-10%
Percentage reduction in ovarian cancer with OCP use for 6 years
50%
Percentage reduction in endometrial cancer with OCP use for 4 years
60%